Hubungan Penyakit Komorbid dengan Status Mortalitas Pasien COVID-19
Abstract
Abstract. Coronavirus disease-19 (COVID-19) is a disease caused by infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). From January to May 20, 2020, a total of 4,806,299 people have been infected and caused 318,599 deaths worldwide. One of the risk factors for COVID-19 is comorbid diseases. Individuals who have comorbidities can make COVID-19 more severe and can increase mortality. The purpose of this study was to determine the relationship between comorbid diseases and mortality status of COVID-19 patients. This study was observational analytic using a cross-sectional study. The study was conducted from February – August 2023. Research materials were taken from medical records, obtained 184 secondary data that met the inclusion criteria. Data were collected using total sampling and analyzed using the Fisher method. The results showed that the number of patients who had comorbidities was 77.7% dominated by lung disease (48.4%). There is a relationship between comorbid diseases and mortality status with a p value of 0.000. This result can occur because it is influenced by various worsening mechanisms that occur in individuals with comorbid diseases.
Abstrak. Coronavirus disease-19 (COVID-19) adalah suatu penyakit yang disebabkan oleh infeksi severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Terhitung sejak Januari sampai 20 Mei 2020, sejumlah 4.806.299 orang telah terinfeksi dan menyebabkan 318.599 kematian di seluruh dunia. Salah satu faktor risiko COVID-19 penyakit komorbid. Individu yang mempunyai penyakit penyerta dapat menyebabkan COVID-19 yang dideritanya menjadi lebih berat dan dapat meningkatkan angka mortalitas. Tujuan penelitian ini adalah untuk mengetahui hubungan penyakit komorbid dengan status mortalitas pasien COVID-19. Penelitian ini adalah observasional analitik menggunakan cross-sectional study. Penelitian dilakukan dari Februari – Agustus 2023. Bahan penelitian diambil dari rekam medis, didapatkan 184 data sekunder yang memenuhi kriteria inklusi. Pengambilan data menggunakan total sampling dan dianalisis menggunakan metode Fisher. Hasil penelitian menunjukkan jumlah pasien yang memiliki komorbid adalah 77.7% yang didominasi oleh penyakit paru (48,4%). Terdapat hubungan antara penyakit komorbid dengan status mortalitas dengan p value 0,000. Hasil ini bisa terjadi karena dipengaruhi oleh adanya berbagai mekanisme perburukan yang terjadi pada individu dengan penyakit komorbid.
References
M. Ciotti, M. Ciccozzi, A. Terrinoni, W.-C. Jiang, C.-B. Wang, dan S. Bernardini, “The COVID-19 pandemic,” Crit Rev Clin Lab Sci, vol. 57, no. 6, hlm. 365–388, 2020, doi: 10.1080/10408363.2020.1783198.
“Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/413/2020 - Regulasi | Covid19.go.id.” Diakses: 26 November 2022. (Daring). Tersedia pada: https://covid19.go.id/id/p/regulasi/keputusan-menteri-kesehatan-republik-indonesia-nomor-hk0107menkes4132020
“Virus origin / Origins of the SARS-CoV-2 virus.” Diakses: 3 November 2022. (Daring). Tersedia pada: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/origins-of-the-virus
C. L. Atzrodt dkk., “A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2”, doi: 10.1111/febs.15375.
J. Rashedi, B. M. Poor, V. A.-I. Med, dan undefined 2020, “Risk factors for COVID-19,” infezmed.it, vol. 4, hlm. 469–474, 2020, Diakses: 9 Desember 2022. (Daring). Tersedia pada: https://www.infezmed.it/media/journal/Vol_28_4_2020_2.pdf
A. Gasmi dkk., “Interrelations between COVID-19 and other disorders,” Clinical Immunology, vol. 224, Mar 2021, doi: 10.1016/J.CLIM.2020.108651.
B. Wang, R. Li, Z. Lu, dan Y. Huang, “Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis,” Aging, vol. 12, no. 7, hlm. 6049–6057, Apr 2020, doi: 10.18632/AGING.103000.
A. Sanyaolu dkk., “Comorbidity and its Impact on Patients with COVID-19”, doi: 10.1007/s42399-020-00363-4/Published.
J. jin Zhang, X. Dong, G. hui Liu, dan Y. dong Gao, “Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality,” Clin Rev Allergy Immunol, vol. 64, no. 1, hlm. 90–107, Feb 2023, doi: 10.1007/S12016-022-08921-5.
Z. Salsabila, Y. Triyani, S. A.-J. R. Kedokteran, dan undefined 2023, “Diabetes Melitus sebagai Komorbiditas Utama terhadap Mortalitas Pasien COVID-19,” journals.unisba.ac.idZ Salsabila, Y Triyani, S AchmadJurnal Riset Kedokteran, 2023•journals.unisba.ac.id, doi: 10.29313/jrk.v3i2.3000.
I. Djaharuddin, S. Munawwarah, A. Nurulita, M. I.-G. sanitaria, dan undefined 2021, “Comorbidities and mortality in COVID-19 patients,” Elsevier, Diakses: 22 Desember 2023. (Daring). Tersedia pada: https://www.sciencedirect.com/science/article/pii/S0213911121002880
J. Malik, S. Ahmed, M. Shinde, … M. A.-S. journal of, dan undefined 2022, “The impact of COVID-19 on comorbidities: a review of recent updates for combating it,” Elsevier, Diakses: 20 Desember 2023. (Daring). Tersedia pada: https://www.sciencedirect.com/science/article/pii/S1319562X22000821
Pratama SN, 1 P, Garna H, Akbar MR. Hubungan Indeks Massa Tubuh, Kualitas Tidur, dan Tekanan Darah dengan Tingkat Stres Karyawan Pabrik PT Primastra Sandang Lestari Bandung Tahun 2022 [Internet]. Vol. 1. 2023. Available from: https://journal.sbpublisher.com/index.php/pharmacomedic
D. Fernández-Ayala, P. N.-E. gerontology, dan undefined 2020, “Age-related mitochondrial dysfunction as a key factor in COVID-19 disease,” Elsevier, Diakses: 22 Desember 2023. (Daring). Tersedia pada: https://www.sciencedirect.com/science/article/pii/S0531556520304952
K. Bajgain, S. Badal, B. Bajgain, M. S.-A. journal of, dan undefined 2021, “Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature,” Elsevier, Diakses: 22 Desember 2023. (Daring). Tersedia pada: https://www.sciencedirect.com/science/article/pii/S0196655320306374
M. Biswas, S. Rahaman, T. K. Biswas, Z. Haque, dan B. Ibrahim, “Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis,” Intervirology, vol. 64, no. 1, hlm. 36–47, Jan 2021, doi: 10.1159/000512592.
“WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data.” Diakses: 11 Januari 2023. (Daring). Tersedia pada: https://covid19.who.int/
D. A. Salsabilla and F. Y. Anggara, “Gambaran Kejadian Kematian Penderita COVID-19 di Kabupaten Pangandaran,” Jurnal Riset Kedokteran, pp. 1–6, Jul. 2023, doi: 10.29313/jrk.vi.1767.
